Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Exicure, Inc. is a biotechnology company focused on developing nucleic acid therapies targeting RNA. It has historically worked on spherical nucleic acid (SNA) technology for therapeutic applications but has shifted to exploring strategic transactions and asset sales. The company owns a patent portfolio, engages in licensing, and seeks growth through acquisitions and partnerships, primarily in Asia, with no current revenue stream or manufacturing operations.
This description was generated via AI from an annual report. Updated about 1 year ago.